CHIESI VENTURES
Chiesi Ventures is a venture capital firm that invests in early stage opportunities operating in the area of rare and orphan disorders. The company funds research and development opportunities for therapies of rare diseases and aims to improve the quality of diagnosis, disease management, care and therapy to all patients affected by rare diseases. It also aims to accelerate the expansion of the Chiesi network in the U.S. among universities, venture capital investors, rare disease patient organiz... ations, and entrepreneurial companies developing treatments for rare diseases. On September 2, 2014, Chiesi Ventures and A. M. Pappas & Associates announced a strategic collaboration. Chiesi Ventures was founded on September 2, 2014, and is headquartered in Parma, Italy with presence in the United States. It is owned by Chiesi Group.
CHIESI VENTURES
Industry:
Venture Capital
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business GStatic Google Static Content Google Cloud Sectigo SSL
Similar Organizations
Fort Ross Ventures
Fort Ross Ventures is a venture capital firm that invests in early growth stage startups with the proven product, technology.
HealthCare Ventures
HealthCare Ventures is a life science venture capital firm that invests in early clinical stage companies which transform patient care.
Mobius Venture Capital
Mobius Venture Capital is an early-stage venture capital fund that invests in various sectors, including healthcare and infrastructure.
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-06-23 | Glycomine | Chiesi Ventures investment in Series B - Glycomine | 35 M USD |
2021-03-22 | Aura Biosciences | Chiesi Ventures investment in Venture Round - Aura Biosciences | 80 M USD |
2020-12-09 | Reneo Pharmaceuticals | Chiesi Ventures investment in Series B - Reneo Pharmaceuticals | 95 M USD |
2020-06-16 | 4D Molecular Therapeutics | Chiesi Ventures investment in Series C - 4D Molecular Therapeutics | 75 M USD |
2019-08-07 | Glycomine | Chiesi Ventures investment in Series B - Glycomine | 33 M USD |
2018-11-07 | Mirum Pharmaceuticals | Chiesi Ventures investment in Series A - Mirum Pharmaceuticals | 120 M USD |
2018-10-17 | CuraSen Therapeutics | Chiesi Ventures investment in Series A - CuraSen Therapeutics | 54.5 M USD |
2018-10-01 | VelosBio | Chiesi Ventures investment in Series A - VelosBio | 58 M USD |
2018-09-26 | Minoryx Therapeutics | Chiesi Ventures investment in Series B - Minoryx Therapeutics | 21.3 M EUR |
2018-09-05 | 4D Molecular Therapeutics | Chiesi Ventures investment in Series B - 4D Molecular Therapeutics | 90 M USD |